These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

1250 related articles for article (PubMed ID: 10709169)

  • 1. Clinical evaluation of a commercially available oral moisturizer in relieving signs and symptoms of xerostomia in postirradiation head and neck cancer patients and patients with Sjögren's syndrome.
    Rhodus NL; Bereuter J
    J Otolaryngol; 2000 Feb; 29(1):28-34. PubMed ID: 10709169
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The effect of hyperbaric oxygenation on postradiation xerostomia and saliva in patients with head and neck tumours.
    Cankar K; Finderle Z; Jan J
    Caries Res; 2011; 45(2):136-41. PubMed ID: 21447949
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Salivary flow rate and clinical characteristics of patients with xerostomia according to its aetiology.
    Cho MA; Ko JY; Kim YK; Kho HS
    J Oral Rehabil; 2010 Mar; 37(3):185-93. PubMed ID: 20002531
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A pilot study to test the efficacy of oral administration of interferon-alpha lozenges to patients with Sjögren's syndrome.
    Khurshudian AV
    Oral Surg Oral Med Oral Pathol Oral Radiol Endod; 2003 Jan; 95(1):38-44. PubMed ID: 12539025
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Saliva substitute in xerostomic patients with primary Sjögren's syndrome: a single-blind trial.
    Alves MB; Motta AC; Messina WC; Migliari DA
    Quintessence Int; 2004 May; 35(5):392-6. PubMed ID: 15130080
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Association between salivary flow rates, oral symptoms, and oral mucosal status.
    Kaplan I; Zuk-Paz L; Wolff A
    Oral Surg Oral Med Oral Pathol Oral Radiol Endod; 2008 Aug; 106(2):235-41. PubMed ID: 18417382
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Optimizing dry mouth treatment for individuals with Sjögren's syndrome.
    Wu AJ
    Rheum Dis Clin North Am; 2008 Nov; 34(4):1001-10, x. PubMed ID: 18984418
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Patient selection criteria for electrostimulation of salivary production in the treatment of xerostomia secondary to Sjogren's syndrome.
    Erlichman M
    Health Technol Assess Rep; 1990; (8):1-7. PubMed ID: 1369638
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Sjogren's syndrome: pathology, oral presentation, and dental management.
    Sciubba JJ
    Compendium; 1994 Sep; 15(9):1084, 1086, 1088 passim; quiz 1096. PubMed ID: 7987902
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Minor gland saliva flow rate and proteins in subjects with hyposalivation due to Sjogren's syndrome and radiation therapy.
    Eliasson L; Almståhl A; Lingström P; Wikström M; Carlén A
    Arch Oral Biol; 2005 Mar; 50(3):293-9. PubMed ID: 15740707
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Salivary gland dysfunction and xerostomia in Sjögren's syndrome.
    Jensen SB; Vissink A
    Oral Maxillofac Surg Clin North Am; 2014 Feb; 26(1):35-53. PubMed ID: 24287192
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A comparison of salivary gland hypofunction in primary and secondary Sjögren's syndrome.
    Dawson LJ; Holt DJ; Higham SM; Longman LP; Field EA
    Oral Dis; 2001 Jan; 7(1):28-30. PubMed ID: 11354918
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Evaluation of palatal saliva flow rate and oral manifestations in patients with Sjögren's syndrome.
    Márton K; Boros I; Varga G; Zelles T; Fejérdy P; Zeher M; Nagy G
    Oral Dis; 2006 Sep; 12(5):480-6. PubMed ID: 16910919
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Dose-volume modeling of salivary function in patients with head-and-neck cancer receiving radiotherapy.
    Blanco AI; Chao KS; El Naqa I; Franklin GE; Zakarian K; Vicic M; Deasy JO
    Int J Radiat Oncol Biol Phys; 2005 Jul; 62(4):1055-69. PubMed ID: 15990009
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Salivary status in patients treated for head and neck cancer.
    Dawes C; Odlum O
    J Can Dent Assoc; 2004 Jun; 70(6):397-400. PubMed ID: 15175120
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Dry mouth: aging and oral health.
    Navazesh M
    Compend Contin Educ Dent; 2002 Oct; 23(10 Suppl):41-8. PubMed ID: 12790016
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Does radiation dose to the salivary glands and oral cavity predict patient-rated xerostomia and sticky saliva in head and neck cancer patients treated with curative radiotherapy?
    Jellema AP; Doornaert P; Slotman BJ; Leemans CR; Langendijk JA
    Radiother Oncol; 2005 Nov; 77(2):164-71. PubMed ID: 16256229
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Dysphagia in patients with three different etiologies of salivary gland dysfunction.
    Rhodus NL; Moller K; Colby S; Bereuter J
    Ear Nose Throat J; 1995 Jan; 74(1):39-42, 45-8. PubMed ID: 7867530
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Impact of wearing an intra-oral lubricating device on oral health in dry mouth patients.
    Frost PM; Shirlaw PJ; Challacombe SJ; Fernandes-Naglik L; Walter JD; Ide M
    Oral Dis; 2006 Jan; 12(1):57-62. PubMed ID: 16390470
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Management of the oral features of Sjögren's syndrome.
    Gravenmade EJ; Vissink A
    Neth J Med; 1992 Apr; 40(3-4):117-24. PubMed ID: 1603201
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 63.